Fibrinogen isoforms as potential blood-based biomarkers of Alzheimer’s disease using a proteomics approach

Alzheimer’s disease (AD), the commonest form of dementia which is characterised by progressive decline in cognitive function, can only be definitively diagnosed after death. Although biomarkers may...